TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 176 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,484,657 | -41.8% | 166,069 | 0.0% | 0.14% | -32.0% |
| Q2 2023 | $2,550,820 | -31.7% | 166,069 | 0.0% | 0.21% | -33.3% |
| Q1 2023 | $3,734,892 | +6.9% | 166,069 | 0.0% | 0.31% | +3.7% |
| Q4 2022 | $3,492,431 | -14.7% | 166,069 | 0.0% | 0.30% | -8.0% |
| Q3 2022 | $4,092,000 | +1.7% | 166,069 | 0.0% | 0.32% | -7.7% |
| Q2 2022 | $4,024,000 | -6.0% | 166,069 | 0.0% | 0.35% | +6.0% |
| Q1 2022 | $4,280,000 | -17.0% | 166,069 | 0.0% | 0.33% | +0.6% |
| Q4 2021 | $5,155,000 | +28.0% | 166,069 | 0.0% | 0.33% | +35.4% |
| Q3 2021 | $4,027,000 | +66.2% | 166,069 | 0.0% | 0.24% | +81.3% |
| Q2 2021 | $2,423,000 | -41.6% | 166,069 | 0.0% | 0.13% | -43.2% |
| Q1 2021 | $4,147,000 | -3.6% | 166,069 | +5.2% | 0.24% | +4.4% |
| Q4 2020 | $4,304,000 | – | 157,900 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |